{"text": ["This", "Biotech", "Stock", "Just", "Flew", "To", "A", "Record", "After", "Topping", "Pfizer", "In", "A", "Study"], "created_at": "2019-03-04 21:24:56"}
{"text": ["Here's", "Why", "Ascendis", "Pharma", "Is", "Rocketing", "Higher", "Today"], "created_at": "2019-03-04 19:06:27"}
{"text": ["Here's", "Why", "Ascendis", "Pharma", "Is", "Rocketing", "Higher", "Today"], "created_at": "2019-03-04 19:06:27"}
{"text": ["Here&apos;s", "Why", "Ascendis", "Pharma", "Is", "Rocketing", "Higher", "Today"], "created_at": "2019-03-04 17:31:00"}
{"text": ["Can", "This", "Biotech", "Puppy", "Run", "With", "the", "Big", "Dogs?"], "created_at": "2019-03-04 17:16:07"}
{"text": ["Can", "This", "Biotech", "Puppy", "Run", "With", "the", "Big", "Dogs?"], "created_at": "2019-03-04 17:16:07"}
{"text": ["AbbVie", "Gets", "CHMP", "Nod", "for", "Psoriasis", "Candidate", "Risankizumab"], "created_at": "2019-03-04 17:12:01"}
{"text": ["AbbVie", "Gets", "CHMP", "Nod", "for", "Psoriasis", "Candidate", "Risankizumab"], "created_at": "2019-03-04 17:12:01"}
{"text": ["Pfizer", "or", "Mylan:", "Who", "Is", "Expected", "to", "Report", "Faster", "EPS", "Growth?"], "created_at": "2019-03-04 16:50:02"}
{"text": ["Pfizer", "Inc.", "--", "Moody's", "assigns", "A1", "rating", "to", "Pfizer's", "notes;", "stable", "outlook"], "created_at": "2019-03-04 16:25:08"}
{"text": ["Pfizer", "and", "Mylan:", "What", "to", "Expect", "from", "Revenue", "Growth", "in", "2019"], "created_at": "2019-03-04 15:20:02"}
{"text": ["AbbVie", "Gets", "CHMP", "Nod", "for", "Psoriasis", "Candidate", "Risankizumab"], "created_at": "2019-03-04 15:05:03"}
{"text": ["Can", "This", "Biotech", "Puppy", "Run", "With", "the", "Big", "Dogs?"], "created_at": "2019-03-04 14:19:00"}
{"text": ["Phibro", "Animal", "Health", "Corporation", "(PAHC)", "Ex-Dividend", "Date", "Scheduled", "for", "March", "05,", "2019"], "created_at": "2019-03-04 14:17:13"}
{"text": ["Phibro", "Animal", "Health", "Corporation", "(PAHC)", "Ex-Dividend", "Date", "Scheduled", "for", "March", "05,", "2019"], "created_at": "2019-03-04 14:17:13"}
{"text": ["Why", "Sangamo", "Therapeutics", "Lost", "22.9%", "of", "Its", "Value", "in", "February"], "created_at": "2019-03-04 14:15:32"}
{"text": ["Why", "Sangamo", "Therapeutics", "Lost", "22.9%", "of", "Its", "Value", "in", "February"], "created_at": "2019-03-04 14:15:32"}
{"text": ["What", "Analysts", "Recommend", "for", "Pfizer", "and", "Mylan", "in", "March"], "created_at": "2019-03-04 13:48:39"}
{"text": ["Market", "Trends", "Toward", "New", "Normal", "in", "Pfizer,", "Hyatt", "Hotels,", "Wipro,", "Garmin,", "Ameren,", "and", "Qorvo", "\u2014", "Emerging", "Consolidated", "Expectations,", "Analyst", "Ratings"], "created_at": "2019-03-04 13:20:00"}
{"text": ["BioXcel", "Therapeutics", "Announces", "Addition", "of", "Merck", "KGaA,", "Darmstadt,", "Germany,", "and", "Pfizer", "to", "Clinical", "Collaboration", "with", "Nektar", "for", "Development", "of", "Triple-combination", "Therapy", "in", "Pancreatic", "Cancer"], "created_at": "2019-03-04 13:00:00"}
